Sivia Capital Partners, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 2012032
Mill Valley, CA
Position in NBIX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,616,972
+$1,188,949 QoQ
Shares Held
9,594
+195.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#340
of 768 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sivia Capital Partners, LLC holds $3,958,512 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (40.8% of the industry book) .
All Filings in NBIX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,616,972 | 9,594 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $428,023 | 3,249 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,006,993 | 7,100 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $536,813 | 3,824 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $215,181 | 1,712 | Shares | Sole | 2025-09-24 | |
| No filing history on record for this holder in this stock. | ||||||